Vault curators are becoming a key source of DeFi liquidity. Their role in managing risk and offering predictable returns are boosting the position of Morpho andVault curators are becoming a key source of DeFi liquidity. Their role in managing risk and offering predictable returns are boosting the position of Morpho and

Vault curators hit peak activity as Morpho drives DeFi lending growth

2026/01/16 23:36
3 min read

Vault curators are reaching peak levels of activity, becoming a key growth driver for DeFi. Curators have been growing their footprint, expanding the value locked in the Morpho protocol. 

Vault curators are becoming a notable element in the growth of DeFi. The rise of top curators boosted the value locked on Morpho, leading to a greater expansion of DeFi lending. 

As Cryptopolitan reported earlier, risk curators or vault curators took off in 2025, but faced stress tests for some of the vaults. Vault curators had to be careful about resource utilization and the risks of their high-yield vaults. 

Vault curators become the growth driver for DeFiSteakhouse Finance increased its value under management, with most inflows into its USDC vaults. | Source: Token Terminal

The growth of the sector boosted all curators, though specific risk managers noted even larger growth for their own activity. Curators are no longer just technically spreading funds to different vaults, but are actively managing risks. 

Based on Token Terminal data, curators saw a rapid increase in total deposits, with some of the top projects doubling their value locked. 

Steakhouse leads vault curators

Steakhouse is the leading vault curator, with the highest value locked. Around 52.5% of the value deposits are in USDC, with smaller vaults using USDT or ETH. 

Steakhouse recently broke above $1.8B on all its vaults, extending its growth despite short-term shocks and several smaller vaults that suffered from low liquidity.

The Steakhouse vaults have actively unrolled to Coinbase users, with new apps and wallets added as partners. The expansion of USDC and demand for passive yield turned Steakhouse into the top risk curator. 

The Steakhouse USDC vault on Morpho has a top safety profile, with a 3.6% yield. The vault holds $436.95M, with over $110M in available liquidity, remaining accessible to borrowers, as well as lenders that may want to withdraw their stake. 

Morpho added $1.1B in January

Morpho reflected the attractiveness of curated vaults. The role of Steakhouse, Gauntlet, Spark, and Smokehouse was to attract new users. 

Morpho locked in $6.91B in mid-January, up from a local low of $5.79B at the end of 2025. The growth also happened with the rise of Morpho V2. The new version will allow even more flexible lending by also bringing off-chain lending agreements to the protocol. Morpho V2 also allows custom rates, terms of the loan, grace periods, and collateral adjustments. 

Onchain lending is expected to expand in 2026, driven mostly by Aave and Morpho. In total, risk curators carry $6.58B, as the value locked recovered in early 2026. Just behind Steakhouse Financial, Gauntlet, Sentora, MEV Capital, and others are still expanding their influence.

If you're reading this, you’re already ahead. Stay there with our newsletter.

Market Opportunity
MORPHO Logo
MORPHO Price(MORPHO)
$1,622
$1,622$1,622
-%0,20
USD
MORPHO (MORPHO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03